Jörn Sträter
Institute of Pathology
University of Ulm
Albert-Einstein-Allee 11
D-89081 Ulm
Germany
Name/email consistency: high
- Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease. Sträter, J., Hinz, U., Hasel, C., Bhanot, U., Mechtersheimer, G., Lehnert, T., Möller, P. Gut (2005)
- CD95 (Fas/APO-1)/CD95L in the gastrointestinal tract: fictions and facts. Sträter, J., Möller, P. Virchows Arch. (2003)
- TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections. Sträter, J., Walczak, H., Pukrop, T., Von Müller, L., Hasel, C., Kornmann, M., Mertens, T., Möller, P. Gastroenterology (2002)
- CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies. Sträter, J., Walczak, H., Hasel, C., Melzner, I., Leithäuser, F., Möller, P. Cell Death Differ. (2001)
- CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Sträter, J., Wellisch, I., Riedl, S., Walczak, H., Koretz, K., Tandara, A., Krammer, P.H., Möller, P. Gastroenterology (1997)